Posted on 6/8/17
Groundbreaking Solution for Med Device and Pharmaceutical Industries' MDM Challenges Delivered Through New EnCompass App
121nexus, a leader in utilizing image recognition technology to provide a new solution to the challenge of master data management (big data), will demo the new . . .
Posted on 6/7/17
Top Health Stocks to Buy Now
What are the top health stocks to buy now? There is a wide range of U.S. and international healthcare and medical choices to invest in. Three . . .
Posted on 6/7/17
Eleven Biotherapeutics to Collaborate with AstraZeneca and the National Cancer Institute
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing a broad pipeline of novel product candidates based on its Targeted Protein Therapeutics (TPTs) . . .
Posted on 6/6/17
Bristol-Myers Squibb (BMY) Investor Presentation - Slideshow
The following slide deck was published by Bristol-Myers Squibb Company in conjunction with this event. 135READ FULL ARTICLE HERE
Posted on 6/6/17
Is Ironwood's Growth About to Slow?
Ironwood Pharmaceuticals (NASDAQ:IRWD) shares are nudging up against 52-week highs because of optimism surrounding Linzess, a drug used in treating chronic idiopathic constipation (CIC) and irritable . . .
Posted on 6/6/17
3 Biotech Stocks to Buy If You've Never Bought a Biotech Stock
If you don't have biotech stocks in your investing portfolio, why not? For many people, the answer is that they think biotech stocks are too risky. . . .
Posted on 6/6/17
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, announced that, on June 1, 2017, . . .
Posted on 6/6/17
Seres Therapeutics Announces Completion of Enrollment for SER-287 Phase 1b Study in Patients with Ulcerative Colitis
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (NASDAQ:MCRB) today announced that it has completed enrollment for its ongoing SER-287 Phase 1b clinical study of 58 patients suffering from . . .
Posted on 6/5/17
3 Biotech Stocks to Buy If You've Never Bought a Biotech Stock
If you don't have biotech stocks in your investing portfolio, why not? For many people, the answer is that they think biotech stocks are too risky. . . .
Posted on 6/5/17
Check-Cap Ltd. Closes $2.69 Million Financing
Check-Cap Ltd. (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced the . . .
Posted on 6/5/17
Mersana Therapeutics Poised for $75M IPO
Cambridge, MA-based Mersana Therapeutics (MRSN) is set for its IPO that is expected to raise $75M.The clinical-stage biopharmaceutical firm develops antibody-drug conjugates to treat cancer. Its . . .
Posted on 6/2/17
Pressure BioSciences Announces One-for-Thirty Reverse Stock Split
Pressure BioSciences, Inc. (OTCQB: PBIO) announced a one-for-thirty reverse split of its common stock effective as of Monday, June 5, 2017. The shares underlying the Company's . . .
Posted on 6/2/17
Xenetic Biosciences Hits A Bit Of A Snag, But Still Highly Promising
Xenetic Biosciences (NASDAQ:XBIO), a biopharmaceutical company which focuses on the research and development of biologic drugs and novel oncology therapeutics, recently received an update from its . . .
Posted on 6/1/17
Better Buy: Biogen Inc. vs. Gilead Sciences Inc.
Two big biotechs have been big busts for investors so far in 2017. Shares of Biogen(NASDAQ:BIIB) and Gilead Sciences (NASDAQ:GILD) are both down year to date, . . .
Posted on 6/1/17
Boston Healthcare Associates and Data Information Intelligence Announce Global Life Sciences Data Commercialization Partnership
BOSTON & BERLIN & LEIPZIG, Germany--(BUSINESS WIRE)--Boston Healthcare Associates, Inc. (Boston Healthcare), a global life sciences consultancy, and Data Information Intelligence GmbH (dii) today announced a . . .
Posted on 6/1/17
Sanofi Genzyme Recognizes Ninth Annual World MS Day
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sanofi Genzyme, the specialty care global business unit of Sanofi, joins the global multiple sclerosis (MS) community today in recognition of the ninth annual . . .
Posted on 5/31/17
Berkshire Hathaway: Measuring Performance
Long-time readers of Berkshire Hathaway's (BRK.A,BRK.B) annual reports may have noticed a change in the opening pages of the latest report. From 2010-2015 there was a . . .
Posted on 5/31/17
CVS Pharmacy Opens First Retail Location in Colorado
CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced the grand opening of its first ever standalone store in Colorado. The new store at . . .
Posted on 5/30/17
Does Cognizant Technology Fit the Bill as Buffett's Ideal Business?
IMAGE SOURCE: THE MOTLEY FOOL.At Berkshire Hathaway's (NYSE:BRK-B) annual meeting earlier this month, an investor asked Warren Buffett about the company's shift from investing in high-return, . . .
Posted on 5/30/17
Better Buy: Celgene Corporation vs. Bristol-Myers Squibb
Investors haven't been too enamored with Celgene (NASDAQ:CELG) and Bristol-Myers Squibb (NYSE:BMY) lately. Both have super-successful cancer drugs and are making plenty of money. However, neither . . .
Posted on 5/30/17
Silicon Therapeutics Announces Recipient of the First Open Science Fellowship
BOSTON--(BUSINESS WIRE)--Silicon Therapeutics, an integrated computational drug discovery company creating novel small molecule therapeutics for diseases with challenging protein targets, is pleased to announce that the . . .
Posted on 5/30/17
Sunovion Receives Complete Response Letter from FDA
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the New Drug . . .
Posted on 5/29/17
X4 Pharmaceuticals Announces Initiation of the Phase 2 Expansion of its Phase 1/2 Study of X4P-001 in Patients
Phase 2 dose of X4P-001 in combination with Inlyta® selected from ongoing Phase 1/2 studyX4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 inhibitor drugs . . .
Posted on 5/26/17
Merrimack Announces Management Change
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) today announced the resignation of Dr. Yasir Al-Wakeel as Chief Financial Officer and Head of Corporate Development, effective June 9, 2017. . . .
Posted on 5/26/17
Insulet Corp. Ranked #4 on Forbes 2017 Most Innovative Growth Companies List
BILLERICA, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today . . .
Boston
